Skills transfer from the DaVinci® system to the Hugo™ RAS system

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Skills transfer from the DaVinci® system to the Hugo™ RAS system. / Olsen, Rikke Groth; Karas, Vladimir; Bjerrum, Flemming; Konge, Lars; Stroomberg, Hein Vincent; Dagnæs-Hansen, Julia Abildgaard; Røder, Andreas.

I: International Urology and Nephrology, Bind 56, 2024, s. 389–397.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Olsen, RG, Karas, V, Bjerrum, F, Konge, L, Stroomberg, HV, Dagnæs-Hansen, JA & Røder, A 2024, 'Skills transfer from the DaVinci® system to the Hugo™ RAS system', International Urology and Nephrology, bind 56, s. 389–397. https://doi.org/10.1007/s11255-023-03807-7

APA

Olsen, R. G., Karas, V., Bjerrum, F., Konge, L., Stroomberg, H. V., Dagnæs-Hansen, J. A., & Røder, A. (2024). Skills transfer from the DaVinci® system to the Hugo™ RAS system. International Urology and Nephrology, 56, 389–397. https://doi.org/10.1007/s11255-023-03807-7

Vancouver

Olsen RG, Karas V, Bjerrum F, Konge L, Stroomberg HV, Dagnæs-Hansen JA o.a. Skills transfer from the DaVinci® system to the Hugo™ RAS system. International Urology and Nephrology. 2024;56:389–397. https://doi.org/10.1007/s11255-023-03807-7

Author

Olsen, Rikke Groth ; Karas, Vladimir ; Bjerrum, Flemming ; Konge, Lars ; Stroomberg, Hein Vincent ; Dagnæs-Hansen, Julia Abildgaard ; Røder, Andreas. / Skills transfer from the DaVinci® system to the Hugo™ RAS system. I: International Urology and Nephrology. 2024 ; Bind 56. s. 389–397.

Bibtex

@article{036016705d0943138e4062ad57c85721,
title = "Skills transfer from the DaVinci{\textregistered} system to the Hugo{\texttrademark} RAS system",
abstract = "Purpose: Recently, the robotic surgical system, Hugo{\texttrademark} was approved for clinical use. The transfer of skills is important for understanding the implementation of surgical innovation. We explored the transfer of skills from the DaVinci{\textregistered} to the Hugo{\texttrademark} by studying the learning curve and short-term patient outcomes during radical prostatectomy (RARP). Methods: We examined the transfer of skills from one surgeon performing RARP from the first case with the Hugo{\texttrademark} system in April 2022. The surgeon had previously performed > 1000 RARPs using DaVinci{\textregistered}. Perioperative and clinical outcomes were collected for procedures on both Hugo{\texttrademark} and DaVinci{\textregistered}. Patient follow-up time was 3 months. Results: Nineteen Hugo{\texttrademark} cases and 11 DaVinci{\textregistered} cases were recorded. No clinically relevant difference in procedure time was found when transferring to Hugo{\texttrademark}. Patients operated using Hugo{\texttrademark} had more contacts postoperatively compared to the DaVinci{\textregistered}, all Clavien–Dindo (CD) grade 1 (53% vs 18%). Three patients from the Hugo{\texttrademark} group were re-admitted within 30 days with catheter malfunction (CD grade 1), infection without a focus (CD grade 2), and ileus due to a hernia in the port hole (CD grade 3b). The 3-month follow-up showed similar results in prostate-specific antigen levels (PSA) and erectile dysfunction between the two robotic systems, but a higher incidence of incontinence was found for the Hugo{\texttrademark}. Conclusion: We observed that the skills of an experienced robotic surgeon are transferable from DaVinci{\textregistered} to Hugo{\texttrademark} when performing RARP. No obvious benefits were found for using Hugo{\texttrademark} compared to DaVinci{\textregistered} for RARP although this needs confirmatory studies.",
keywords = "Hugo{\texttrademark} RAS, IDEAL framework, Learning curve, Prostate cancer, Robot-assisted radical prostatectomies, Urology",
author = "Olsen, {Rikke Groth} and Vladimir Karas and Flemming Bjerrum and Lars Konge and Stroomberg, {Hein Vincent} and Dagn{\ae}s-Hansen, {Julia Abildgaard} and Andreas R{\o}der",
note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",
year = "2024",
doi = "10.1007/s11255-023-03807-7",
language = "English",
volume = "56",
pages = "389–397",
journal = "International Urology and Nephrology",
issn = "0301-1623",
publisher = "Springer",

}

RIS

TY - JOUR

T1 - Skills transfer from the DaVinci® system to the Hugo™ RAS system

AU - Olsen, Rikke Groth

AU - Karas, Vladimir

AU - Bjerrum, Flemming

AU - Konge, Lars

AU - Stroomberg, Hein Vincent

AU - Dagnæs-Hansen, Julia Abildgaard

AU - Røder, Andreas

N1 - Publisher Copyright: © 2023, The Author(s).

PY - 2024

Y1 - 2024

N2 - Purpose: Recently, the robotic surgical system, Hugo™ was approved for clinical use. The transfer of skills is important for understanding the implementation of surgical innovation. We explored the transfer of skills from the DaVinci® to the Hugo™ by studying the learning curve and short-term patient outcomes during radical prostatectomy (RARP). Methods: We examined the transfer of skills from one surgeon performing RARP from the first case with the Hugo™ system in April 2022. The surgeon had previously performed > 1000 RARPs using DaVinci®. Perioperative and clinical outcomes were collected for procedures on both Hugo™ and DaVinci®. Patient follow-up time was 3 months. Results: Nineteen Hugo™ cases and 11 DaVinci® cases were recorded. No clinically relevant difference in procedure time was found when transferring to Hugo™. Patients operated using Hugo™ had more contacts postoperatively compared to the DaVinci®, all Clavien–Dindo (CD) grade 1 (53% vs 18%). Three patients from the Hugo™ group were re-admitted within 30 days with catheter malfunction (CD grade 1), infection without a focus (CD grade 2), and ileus due to a hernia in the port hole (CD grade 3b). The 3-month follow-up showed similar results in prostate-specific antigen levels (PSA) and erectile dysfunction between the two robotic systems, but a higher incidence of incontinence was found for the Hugo™. Conclusion: We observed that the skills of an experienced robotic surgeon are transferable from DaVinci® to Hugo™ when performing RARP. No obvious benefits were found for using Hugo™ compared to DaVinci® for RARP although this needs confirmatory studies.

AB - Purpose: Recently, the robotic surgical system, Hugo™ was approved for clinical use. The transfer of skills is important for understanding the implementation of surgical innovation. We explored the transfer of skills from the DaVinci® to the Hugo™ by studying the learning curve and short-term patient outcomes during radical prostatectomy (RARP). Methods: We examined the transfer of skills from one surgeon performing RARP from the first case with the Hugo™ system in April 2022. The surgeon had previously performed > 1000 RARPs using DaVinci®. Perioperative and clinical outcomes were collected for procedures on both Hugo™ and DaVinci®. Patient follow-up time was 3 months. Results: Nineteen Hugo™ cases and 11 DaVinci® cases were recorded. No clinically relevant difference in procedure time was found when transferring to Hugo™. Patients operated using Hugo™ had more contacts postoperatively compared to the DaVinci®, all Clavien–Dindo (CD) grade 1 (53% vs 18%). Three patients from the Hugo™ group were re-admitted within 30 days with catheter malfunction (CD grade 1), infection without a focus (CD grade 2), and ileus due to a hernia in the port hole (CD grade 3b). The 3-month follow-up showed similar results in prostate-specific antigen levels (PSA) and erectile dysfunction between the two robotic systems, but a higher incidence of incontinence was found for the Hugo™. Conclusion: We observed that the skills of an experienced robotic surgeon are transferable from DaVinci® to Hugo™ when performing RARP. No obvious benefits were found for using Hugo™ compared to DaVinci® for RARP although this needs confirmatory studies.

KW - Hugo™ RAS

KW - IDEAL framework

KW - Learning curve

KW - Prostate cancer

KW - Robot-assisted radical prostatectomies

KW - Urology

U2 - 10.1007/s11255-023-03807-7

DO - 10.1007/s11255-023-03807-7

M3 - Journal article

C2 - 37773578

AN - SCOPUS:85172899536

VL - 56

SP - 389

EP - 397

JO - International Urology and Nephrology

JF - International Urology and Nephrology

SN - 0301-1623

ER -

ID: 370270908